诊断病理学杂志2024,Vol.31Issue(6) :513-516,536.DOI:10.3969/j.issn.1007-8096.2024.05.008

弥漫大B细胞淋巴瘤中ERK和p38的表达及临床病理学意义

Expression of ERK and p38 in diffuse large B-cell lymphoma and their clinicopathological significance

马明福 李君娜 于靖雯 王小树 穆海拜提·阿卜拉江 崔文丽
诊断病理学杂志2024,Vol.31Issue(6) :513-516,536.DOI:10.3969/j.issn.1007-8096.2024.05.008

弥漫大B细胞淋巴瘤中ERK和p38的表达及临床病理学意义

Expression of ERK and p38 in diffuse large B-cell lymphoma and their clinicopathological significance

马明福 1李君娜 1于靖雯 1王小树 1穆海拜提·阿卜拉江 2崔文丽1
扫码查看

作者信息

  • 1. 新疆医科大学第一附属医院病理科,乌鲁木齐 830054
  • 2. 新疆墨玉县人民医院病理科,新疆墨玉 848100
  • 折叠

摘要

目的 探讨ERK和p38在弥漫大B细胞淋巴瘤(DLBCL)中的表达与各临床病理指标之间的关系,及其与预后的相关性.方法 运用免疫组化检测152例弥漫大B细胞淋巴瘤中ERK和p38阳性表达情况,应用SPSS 23.0软件分析其与各临床病理指标的关系.结果 在DLBCL中,ERK、p38的阳性率分别为68.4%、50%,ERK、p38在肿瘤直径>4 cm中阳性表达率高,差异均有统计学意义,且均与肿瘤直径显著正相关.p38在结内病变和结外侵犯>2个淋巴结阳性表达率更高,差异有统计学意义,且与结外侵犯正相关,与原发部位负相关.多因素分析中,表现状态评分、LDH水平和R-CHOP治疗是影响DLBCL患者总生存期的独立危险因素.结论 这些发现表明ERK和p38在DLBCL中的致癌作用,提示它们是DLBCL潜在的治疗靶点.

Abstract

Objective To investigate the relationship between the expression of ERK and p38 in diffuse large B-cell lymphoma(DLBCL)and various clinicopathological indicators,as well as the correlation with prognosis.Methods The positive expression of ERK and p38 in 152 cases of DLBCL was detected by immunohistochemistry.The relationship between ERK and P38 was analyzed by SPSS 23.0 software.Results In DLBCL,the positive rates of ERK and p38 were 68.4%and 50%,respectively.The positive rates of ERK and p38 were high in tumor diameter>4 cm,and the differences were statistically significant,and both were significantly positively correlated with tumor diameter.The positive expression rate of p38 was higher in nodal lesions and extranodal invasion>2 lymph nodes,and the difference was statistically significant,and it was positively correlated with extranodal invasion and negatively correlated with the primary site.In multivariate analysis,performance status score,LDH level,and R-CH0P treatment were independent risk factors for overall survival in DLBCL patients.Conclusion These findings indicate the carcinogenic role of ERK and p38 in DLBCL,suggesting that they are potential therapeutic targets for DLBCL.

关键词

弥漫大B细胞淋巴瘤/ERK/p38/临床病理/靶点

Key words

Diffuse large B-cell lymphoma/ERK/p38/Clinicopathology/Target

引用本文复制引用

基金项目

国家自然科学基金(82060038)

国家自然科学基金(82360046)

出版年

2024
诊断病理学杂志
北京军区总医院

诊断病理学杂志

CSTPCD
影响因子:0.663
ISSN:1007-8096
段落导航相关论文